EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nicotinamide metabolism-related signature and lncRNA regulatory network in kidney renal clear cell carcinoma

Pei Dong, Lincong Zhao, Peiyao Shi, Ming Ma, Beixuan Huang, Zhenda Wang, Shaowei Zhang, Huan Liu

PeerJ · 2026

DOI: 10.7717/peerj.21300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2026. Verfasst von Pei Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, RNA, Long Noncoding, Niacinamide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science Research Project of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal carcinoma ranks among the most lethal cancers, primarily attributed to its atypical symptoms and high metastatic potential. The metabolism of nicotinamide (NAM) plays a significant role in the progression of various tumors. However, investigations into the impact of the NAM metabolism-related signature (NMRS) in kidney renal clear cell carcinoma (KIRC) remain insufficient. Clinical and RNA sequencing data (RNA-seq) from 541 KIRC tissues and 72 adjacent normal tissues were extracted from TCGA. NAM metabolism-related genes (NMRGs) were identified through the Molecular Signatures Database. Cox regression analyses (univariate/multivariate) were conducted to develop NMRS. Time-dependent ROC curve analysis showed that this method had good accuracy in predicting 1-year (AUC = 0.691), 3-year (AUC = 0.749), and 5-year (AUC = 0.764) survival. The Receiver Operating Characteristic (ROC) curve from the external RECA-EU dataset (AUC = 0.682) highlights the accurate prognostic assessment of the NMRS. Overall survival (OS) rates across distinct risk groups were compared using KM analysis. The Cox proportional hazards model assessed the influence of clinicopathological factors and risk scores on survival outcomes (HR = 1.437, 95% CI [1.232–1.676]; P < 0.001). Evaluation of the immune microenvironment employed the ESTIMATE and CIBERSORT methods, while enrichment analysis examined biological significance. Correlation analysis determined the link between the expression of checkpoint genes and risk scores. StarBase and miRTarBase facilitated the prediction of target miRNAs and lncRNAs bindingto NMRGs. This study presents a novel framework for identifying prognostic biomarkers and therapeutic targets in KIRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsRNA, Long NoncodingNiacinamideHumansGene Expression Regulation, NeoplasticPrognosisGene Regulatory NetworksROC CurveFemaleMale

Stichwörter der Autor:innen

CoxKIRCNMRGslncRNAmiRNA

Substanzen

RNA, Long NoncodingNiacinamide

Autor:innen und Institutionen

  • The Fourth Hospital of Hebei Medical University, State Grid Hebei Information & Telecommunication Company, Shijiazhuang, Hebei, China.

Förderung

  • Medical Science Research Project of Hebei

Zitieren

APA

Dong, P., Zhao, L., Shi, P., Ma, M., Huang, B., Wang, Z., Zhang, S., & Liu, H. (2026). Nicotinamide metabolism-related signature and lncRNA regulatory network in kidney renal clear cell carcinoma. PeerJ. https://doi.org/10.7717/peerj.21300

Vancouver

Dong P, Zhao L, Shi P, Ma M, Huang B, Wang Z, et al. Nicotinamide metabolism-related signature and lncRNA regulatory network in kidney renal clear cell carcinoma. PeerJ. 2026. doi:10.7717/peerj.21300

BibTeX
@article{Dong2026,
  author = {Dong, Pei and Zhao, Lincong and Shi, Peiyao and Ma, Ming and Huang, Beixuan and Wang, Zhenda and Zhang, Shaowei and Liu, Huan},
  title = {Nicotinamide metabolism-related signature and lncRNA regulatory network in kidney renal clear cell carcinoma},
  journal = {PeerJ},
  year = {2026},
  doi = {10.7717/peerj.21300}
}
Kostenlos starten →